Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case

Yu Ito1, Nobuyasu Awano1, Fumiya Uchiyama2

  • 1Department of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.

Insights

Severe COVID-19 patients on anticoagulation can develop spontaneous muscle hematomas (SMH). Early diagnosis via contrast-enhanced computed tomography (CECT) is crucial for managing bleeding risks in these patients.

Area of Science:

  • Internal Medicine
  • Hematology
  • Radiology

Background:

  • Anticoagulation therapy is standard for hospitalized COVID-19 patients to prevent thrombosis.
  • However, anticoagulation increases the risk of bleeding complications.

Observation:

  • Two Japanese patients with severe COVID-19 developed spontaneous muscle hematomas (SMH) despite therapeutic unfractionated heparin.
  • Hematomas were located in the bilateral iliopsoas muscles and required emergent transcatheter embolization.

Findings:

  • Contrast-enhanced computed tomography (CECT) confirmed SMH in both cases, even with activated partial prothrombin time within the optimal range.
  • This suggests SMH can occur even when coagulation parameters appear controlled.

Implications:

  • Close monitoring of the coagulation system is essential in severe COVID-19 patients receiving anticoagulants.
  • Early diagnosis of bleeding complications, such as SMH, using CECT is critical for timely intervention and management.

Related Concept Videos